Ratings Well Lead Medical Co., Ltd.

Equities

603309

CNE1000021C2

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
12.3 ^CNY	+0.57%		+1.49%	-13.56%

May. 02	Karl Storz and Well Lead Medical Announces Exclusive Agreement for Distribution of Clearpetra Stone-Removal System in the U.S	CI
Apr. 19	Mainland China and Hong Kong stocks fall on Middle East tensions	RE

Strengths

The prospective high growth for the next fiscal years is among the main assets of the company
The group's high margin levels account for strong profits.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
WELL LEAD MEDICAL CO., LTD.	-13.56%	498M	-	-
ABBOTT LABORATORIES	-3.81%	184B		C+
MEDTRONIC PLC	-0.92%	107B		C
BECTON, DICKINSON AND COMPANY	-3.65%	69.44B		A
DEXCOM, INC.	+3.68%	50.37B		B-
CENCORA, INC.	+8.46%	44.82B		B-
HOYA CORPORATION	+3.40%	41.53B		B+
WEST PHARMACEUTICAL SERVICES, INC.	+3.16%	26.84B		A-
METTLER-TOLEDO INTERNATIONAL, INC.	+4.30%	26.73B		B
TERUMO CORPORATION	+15.23%	25.71B		A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes